Skip to content

20-370 - Study Exploring the Effect of Crizanlizumab on Kidney Function in Patients With Chronic Kidney Disease Caused by Sickle Cell Disease

Status: open

A Phase II, multicenter, randomized, open label two arm study comparing the effect of crizanlizumab + standard of care to standard of care alone on renal function in sickle cell disease patients ¡ý 16 years with chronic kidney disease due to sickle cell nephropathy (STEADFAST)

Sickle Cell Disease

Contact Us Or call 251-470-5889

Description

This clinical trial will explore the effects of the drug called crizanlizumab has on kidney function in people with long term kidney disease caused by sickle cell disease (SCD).

This link will open in a new tab or window.